PARP1 transcription was reported to be repressed by lncRNAs in lung cancer [37], hepatocellular carcinoma [38], neuroblastoma [39], thyroid cancer [40], multiple myeloma [41], lung morphogenesis [42] and angiogenesis [43]. Here, PARP1 is linked to neuroblastoma.